Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of respiratory particle emission rates at rest and while speaking or exercising.
Orton CM, Symons HE, Moseley B, Archer J, Watson NA, Philip KEJ, Sheikh S, Saccente-Kennedy B, Costello D, Browne WJ, Calder JD, Bzdek BR, Hull JH, Reid JP, Shah PL. Orton CM, et al. Among authors: shah pl. Commun Med (Lond). 2022 Apr 19;2:44. doi: 10.1038/s43856-022-00103-w. eCollection 2022. Commun Med (Lond). 2022. PMID: 35603287 Free PMC article.
Contemporary Concise Review 2018: Lung cancer and pleural disease.
Conway FM, Garner JL, Orton CM, Srikanthan K, Kemp SV, Shah PL. Conway FM, et al. Among authors: shah pl. Respirology. 2019 May;24(5):475-483. doi: 10.1111/resp.13499. Epub 2019 Feb 16. Respirology. 2019. PMID: 30772946 Free article. Review. No abstract available.
Epithelial Resurfacing: The Bronchial Skin Peel.
Shah PL, Orton C. Shah PL, et al. Am J Respir Crit Care Med. 2020 Sep 1;202(5):641-642. doi: 10.1164/rccm.202004-1097ED. Am J Respir Crit Care Med. 2020. PMID: 32441988 Free PMC article. No abstract available.
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.
Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, Hewitt RJ, Desai SR, Devaraj A, Snelgrove RJ, Molyneaux PL, Garner JL, Peters JE, Shah PL, Lloyd CM, Harker JA. Vijayakumar B, et al. Among authors: shah pl. Immunity. 2022 Mar 8;55(3):542-556.e5. doi: 10.1016/j.immuni.2022.01.017. Epub 2022 Jan 26. Immunity. 2022. PMID: 35151371 Free PMC article.
Comparing aerosol number and mass exhalation rates from children and adults during breathing, speaking and singing.
Archer J, McCarthy LP, Symons HE, Watson NA, Orton CM, Browne WJ, Harrison J, Moseley B, Philip KEJ, Calder JD, Shah PL, Bzdek BR, Costello D, Reid JP. Archer J, et al. Among authors: shah pl. Interface Focus. 2022 Feb 11;12(2):20210078. doi: 10.1098/rsfs.2021.0078. eCollection 2022 Apr 6. Interface Focus. 2022. PMID: 35261733 Free PMC article.
Quantification of Respirable Aerosol Particles from Speech and Language Therapy Exercises.
Saccente-Kennedy B, Archer J, Symons HE, Watson NA, Orton CM, Browne WJ, Harrison J, Calder JD, Shah PL, Costello D, Reid JP, Bzdek BR, Epstein R. Saccente-Kennedy B, et al. Among authors: shah pl. J Voice. 2022 Aug 25:S0892-1997(22)00207-7. doi: 10.1016/j.jvoice.2022.07.006. Online ahead of print. J Voice. 2022. PMID: 36031505 Free article.
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
Shah PL, Orton CM, Grinsztejn B, Donaldson GC, Crabtree Ramírez B, Tonkin J, Santos BR, Cardoso SW, Ritchie AI, Conway F, Riberio MPD, Wiseman DJ, Tana A, Vijayakumar B, Caneja C, Leaper C, Mann B, Samson A, Bhavsar PK, Boffito M, Johnson MR, Pozniak A, Pelly M; PIONEER trial group. Shah PL, et al. Lancet Respir Med. 2023 May;11(5):415-424. doi: 10.1016/S2213-2600(22)00412-X. Epub 2022 Dec 14. Lancet Respir Med. 2023. PMID: 36528039 Free PMC article. Clinical Trial.
212 results